Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. 5¢ INVEX THERAPEUTICS LTD - Discussion. Orphan drug status. Can&apos;t see how this doesn&apos;t push up soon, page-508. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. ASX - General. Created with Sketch. Created with Sketch. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Invex Granted Type C Meeting with FDA, page-2. , page-2. , page-20. ASX - By Stock. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. ASX - Day Tradingis invex releasing 2. Appendix 4E and Annual Report, page-3. We are a team of expert financial advisers each specialising in different, yet complementary areas. Loading interactive chart. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. 0¢ Sentiment: Buy Disclosure: Held. This was roughly 50/50 between lost wages and direct medical costs. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. British Columbia, Selkirk Mountains. Created with Sketch. Forums. 333334. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. ASX - Short Term Trading. Created with Sketch. Charts. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. . Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. Wouldn’t surprised me if they turn this company into something else if he keeps buyingCreated with Sketch. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Loading. ASX - By Stock. 147,415. ASX - By Stock. Latest Posts. ASX - Day TradingSomeone bought $500 stock today at 44 cents. ASX - Short Term Trading. Created with Sketch. Below is the broker data for IXC November to. IXC (ASX) Ann: Trading Halt - HotCopper. Created with Sketch. In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Charts. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. Created with Sketch. Join the HotCopper ASX share market. 10 cents a week and we will be at $2 plus in no time. Last updated 10. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. Latest Posts. Forums. 375,000. . Created with Sketch. Invex Receives Approval for Paediatric Plan from the EMA, page-3. . Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. Join the HotCopper ASX share market forum today for free. IXC Valuation Report MST. Here come the vultures. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. ASX - By Stock. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. 30 Haven’t supported share price since then on market . . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 1956773. Forums. , page-4. Forums. Market . ASX - By Stock. ASX - By Stock. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. But lets not talk about NSB here, we are here to see progress with IXC. Created with Sketch. Charts. Webinvest Pty Ltd<Olsb Unit A/C>. I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. Therefore Id bet the same bet with the same info again. Share "Online registration will open 30 minutes before the Meeting. . Charts. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Last edited by jellyroll: 27/02/23. Created with Sketch. Charts. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. ASX - Short Term Trading. Market . , page-3. ASX - Day TradingCreated with Sketch. 1. ASX - Short Term Trading. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. We are a team of expert financial advisers each specialising in different, yet complementary areas. IXC Price at posting: $1. Created with Sketch. TRP also trades sub cash -5m i believe, haven't checked in a while. Forums. , page-3. Join the HotCopper ASX share market forum today for free. 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. ASX - By Stock. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumFound this article a while back although raises some decent points. ASX - Day TradingAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. rights. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. Share Appreciate the commentary and post. ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Sentiment for Invex Therapeutics Ltd. Join the HotCopper ASX share market forum today for free. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Created with Sketch. Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. Plans & Pricing. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . International Markets. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Just a matter of time really. Notice of Investor Call and Presentation, page-3. . Trading HaltIXC Valuation Report MST. Trading HaltIXC Valuation Report MST. 50%. All IMO IXC Price at posting: 37. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day Trading. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. 0 Million. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC Price at posting. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. IXC needs to be proactive and release a statement. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC “ presented “ about the AGM time to who ? If the company is aware ( as others seem to think) of an individual seller then they need to be proactive and take them out . More progress made towards the start of Phase III, we have now made it on to the clinicltrials. ASX - By Stock. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. Created with Sketch. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. Latest Posts. 59). Notice of Annual General Meeting/Proxy Form, page-2. . ASX - By Stock. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. 64440. ASX - Day Trading. 10 Upvote. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Created with Sketch. ASX - By Stock. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. , page-5. , page-4. Australian finance news, stock quotes, currency information and blogs0. 3¢. 31% more bullish than other Healthcare sector stocks. Created with Sketch. 3¢. Created with Sketch. ASX - Day Trading. . ASX - Short Term Trading. Discover historical prices for IXC. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. ASX - General. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. . Join the HotCopper ASX share market forum today for free. , page-5. 26 area could be wrong and it could go for example to $3. These are 2007 numbers. . ASX - Day TradingCreated with Sketch. Probably been disappointed like all of usCreated with Sketch. . Latest Posts. Created with Sketch. Lucky for you all IXC still sits at only 60 cents. Latest Posts. Join the HotCopper ASX share market forum today for free. . Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. ASX - Day Trading. , page-196. Forums. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. Appreciate your input Dr T. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. 1950. Share Not unexpected. IXC Price at posting: 79. Quarterly Activities/Appendix 4C Cash Flow Report. Created with Sketch. Update - Notification regarding unquoted securities - IXC. . ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. , page-17. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. **Close price adjusted for splits and dividend and/or capital gain distributions. Created with Sketch. 00% 21. Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you. , page-136. . . ASX - Day TradingCreated with Sketch. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. ASX - By Stock. Advertise on HotCopper. Market Cap $102. Charts. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. . ASX - Day TradingI sold around half my shares yesterday at 25c. Forums. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumIXC need to hold a conference call to discuss the announcement - they need to front up. IXC Price at posting: 44. Invex issued US patent for Traumatic Brain Injury. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Invex Granted Type C Meeting with FDA, page-3. Yet since market announcement of Phase 2 completion, this. Andrew Forrest , or his entities have been involved with IXC since inception. 0. . HotCopper has news, discussion, prices and market data on IXUP LIMITED. Created with Sketch. Join the HotCopper ASX share market forum today. AVALANCHE. Learn how it impacts everything we do. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. All IMO IXC Price at posting: 37. Currency in USD 38. Company has options because they have cash. 2 Upvote. Strong buy side, sell side still very thin. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. . Join the HotCopper ASX share market forum today for free. Latest Posts. Join the HotCopper ASX share market forum today for free. Invex Therapeutics Ltd. 30 to $15 in the space of 1 and half years Bios move fast when value is recognised. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Created with Sketch. AX stock on. Invex Therapeutics Ltd. Created with Sketch. 40. 8,369 likes · 140 talking about this · 1,407 were here. is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with. Created with Sketch. , page-5. ASX - By Stock. Given the quality of the posters on the IXC thread I am confident others will do the same. ASX - General. Latest Posts. 79 -0. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. Target our investor community with our suite of Hotcopper Advertising. gov and there is lots of good information about the trial. 38 Biotechnology stocks are valued based on a risk. 06KBNotification of cessation of securities - IXC. Charts. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Also took placement stock @$1. ASX - By Stock. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. ASX - Day TradingIXC: 22/11/2023 1:08 PM : Notification of cessation of securities - IXC 4 pages 23. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. 8M ! Add to my watchlist. Forums. As thread states post your questions here and let’s start compiling a list. LoginJoin Now. . ASX - Day Trading. IAMIncome Asset Management to boost bond sales through partnership with Netwealth. Share IXC needs to be proactive and release a statement. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. ASX - General. . Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Discover historical prices for IXC. ASX - General. 0¢ Sentiment: Buy Disclosure: Held. 40 in May 2020 and has only fallen over the subsequent 36 months. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. More. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - By Stock. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - Day Trading. Created with Sketch. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. ASX - Day TradingNotice of Webinar &amp; Investor PresentationCreated with Sketch. . ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. . ASX - By Stock. 3. 76 (-1. boolish Jellyroll hey. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. Reply. . Forums. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. ASX - By Stock. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. . , page-3. AX stock on Yahoo Finance. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Folks say we are pioneers of craft ice cream in Victoria. Too many factors to make an educated appraisal of buyout pre-Phase 2 or post Phase 2. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. Created with Sketch. About 90 percent of the U. ASX - Day Trading. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Created with Sketch. . ASX - Short Term Trading. Target our investor community with our suite of Hotcopper Advertising opportunities. . 31% more bullish than other Healthcare sector stocks. ASX - By Stock. Transparency is our policy. Notification of cessation of securities - IXC. 0 Great analysis. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. About 90 percent of the U. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. Forums. . A rolling snowball gathers snow as it falls down the hill . ASX - By Stock. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3.